Analysis of the effects of animal fat free diet and aspirin for prostaglandins in patients with myotonic dystrophy

Analysis of the effects of animal fat free diet and aspirin for prostaglandins in patients with myotonic dystrophy - Animal fat free diet and aspirin in patients with myotonic dystrophy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016092

Enrollment

Registered

2014-12-31

Start date

2014-12-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myotonic dystrophy

Interventions

1st stage (1w): animal fat free diet 2nd stage (1w): animal fat free diet and aspirin (330mg/day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Genetically confirmed myotonic dystrophy patients who can take ordinary texture diet.

Exclusion criteria

Exclusion criteria: Patients with severe heart failure, hepatic failure, renal failure, hematological disorders, bleeding tendency or active illnesses (infection, allergic disorders). Patients taking anticoagulant or antiplatelet agents. Patients with active gastrointestinal ulcers. Patients in pregnancy Patients having history of any allergic responses for aspirin. Patients taking anti-inflammaotry or antiallergic agents.

Design outcomes

Primary

Measure	Time frame
Prostaglandins (PGD2, PGE2, etc.) and their metabolites	—

Countries

Japan

Contacts

Public ContactYoshiko Tsuchie

National Hospital Organization Toneyama National Hospital Clinical research center

chiken@toneyama.go.jp06-6853-2001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026